Journal of Diabetes and Endocrinology
Subscribe to JDE
Full Name*
Email Address*

Article Number - 0CB304761030


Vol.7(2), pp. 6-8 , September 2016
DOI: 10.5897/JDE2016.0098
ISSN: 2141-2685



Case Report

Reversal of Idiopathic hypogonadotropic hypogonadism triggered by testosterone therapy



Anish K.
  • Anish K.
  • Vydehi Institute of Medical Sciences, Bangalore, India
  • Google Scholar
Shivaprasad C.
  • Shivaprasad C.
  • Vydehi Institute of Medical Sciences, Bangalore, India
  • Google Scholar
Goel A.
  • Goel A.
  • Vydehi Institute of Medical Sciences, Bangalore, India
  • Google Scholar







 Received: 07 July 2016  Accepted: 12 September 2016  Published: 30 September 2016

Copyright © 2016 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0


A 21-year-old male presented to us with delayed development of secondary sexual characteristics. Based on examination and investigations, a diagnosis of idiopathic hypogonadotropic hypogonadism was made and the patient was started on testosterone therapy. After around a year of therapy the patient had an increase in bilateral testicular volume with increased serum luteinizing hormone (LH) values. The patient was advised to stop treatment. On follow-up there was persistence of increase in LH values with maintenance of normal serum testosterone values. Thus the case highlights the importance of regular follow-up in cases of idiopathic hypogonadotropic hypogonadism to watch for reversal.
 
Key words: Puberty, hypogonadism, reversal.

Fraietta R, Zylberstejn DS, Esteves SC (2013). Hypogonadotropic Hypogonadism revisited. Clinics 68(Suppl 1):81-88.
Crossref

 

Kulshreshtha B, Khadgawat R, Gupta N, Ammini A (2013). Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism. Indian J. Endocrinol. Metab. 17(5):851-854.
Crossref

 
 

MacLusky NJ, Hajszan T, Prange-Kiel J, Leranth C (2006). Androgen modulation of hippocampal synaptic plasticity. Neuro-science 138:957-965.
Crossref

 
 

Mao JF, Xu HL, Duan J, Chen RR, Li L, Li B, Nie M, Min L, Zhang HB, Wu XY (2015). Reversal of idiopathic hypogonadotropic hypogonadism: a cohort study in Chinese patients. Asian J. Androl. 17(3):497-502.

 
 

Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, Hughes VA, Cole LW, Pearce SH, Lee H, Boepple P, Crowley WF Jr, Pitteloud N (2007). Reversal of idiopathic hypogonadotropic hypogonadism. N. Engl. J. Med. 357:863-873.
Crossref

 
 

Root AW (2010). Reversible isolated hypogonadotropic hypogonadism due to mutations in the neurokinin B regulation of gonadotropin‐releasing hormone release. J. Clin. Endocrinol. Metab. 95:2625-2629.
Crossref

 
 

Seminara SB, Hayes FJ, Crowley WF Jr (1998). Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr. Rev. 19:521-539.
Crossref

 
 

Sidhoum VF, Chan YM, Lippincott MF, Balasubramanian R, Quinton R, Plummer L, Dwyer A, Pitteloud N, Hayes FJ, Hall JE, Martin KA, Boepple PA, Seminara SB (2014). Reversal and relapse of hypogonadotropic hypogonadism: Resilience and fragility of the reproductive neuroendocrine system. J. Clin. Endocrinol. Metab. 99(3):861-870.
Crossref

 
 

Tommiska J, Jørgensen N, Raivio T (2013). A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor presenting as reversal of hypogonadotropic hypogonadism and late-onset hypogonadism. Clin. Endocrinol. 78(2):316-317.
Crossref

 

 


APA Anish, K., Shivaprasad, C., & Goel, A. (2016). Reversal of Idiopathic hypogonadotropic hypogonadism triggered by testosterone therapy. Journal of Diabetes and Endocrinology, 7(2), 6-8.
Chicago Anish K., Shivaprasad C. and Goel A.. "Reversal of Idiopathic hypogonadotropic hypogonadism triggered by testosterone therapy." Journal of Diabetes and Endocrinology 7, no. 2 (2016): 6-8.
MLA Anish K., Shivaprasad C. and Goel A.. "Reversal of Idiopathic hypogonadotropic hypogonadism triggered by testosterone therapy." Journal of Diabetes and Endocrinology 7.2 (2016): 6-8.
   
DOI 10.5897/JDE2016.0098
URL http://academicjournals.org/journal/JDE/article-abstract/0CB304761030

Subscription Form